Title:
ＪＡＫ阻害剤の局所製剤
Document Type and Number:
Japanese Patent JP7167280
Kind Code:
B2
Abstract:
This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
More Like This:
| WO/2001/023349 | ACYLSULFONAMIDE DERIVATIVES |
| JP7066627 | Compositions containing tannic acid and their use |
| WO/2018/124835 | NOVEL EXOSOME-BASED ANTICANCER AGENT |
Inventors:
Babnish Parik
Babesh Shah
Krishna Swami Yereswaram
Babesh Shah
Krishna Swami Yereswaram
Application Number:
JP2021157016A
Publication Date:
November 08, 2022
Filing Date:
September 27, 2021
Export Citation:
Assignee:
INCYTE HOLDINGS CORPORATION
International Classes:
A61K31/519; A61K9/107; A61K47/06; A61K47/10; A61K47/14; A61K47/26; A61P17/00; A61P17/06; A61P37/06; A61P37/08; A61P43/00
Attorney, Agent or Firm:
Michiko Matsutani
Yasushi Ochiai
Yasushi Ochiai
Previous Patent: Method for processing multiple decodable indicia
Next Patent: DEVICE AND METHOD FOR CONTROLLING AUTOMATED MECHANISM TRANSMISSION
Next Patent: DEVICE AND METHOD FOR CONTROLLING AUTOMATED MECHANISM TRANSMISSION